Interferon Gamma-1B: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Interferon Gamma-1B. Educational only — not medical advice.
Labeled uses
ACTIMMUNE is indicated for reducing the frequency and severity of serious infections associated with Chronic Granulomatous Disease (CGD). ACTIMMUNE is indicated for delaying time to disease progression in patients with severe, malignant osteopetrosis (SMO).
Source: FDA labeling via NIH DailyMed (set 5d0b1256…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.